TEVAR for Acute Uncomplicated Aortic Dissection: Immediate Repair Versus Medical Therapy

Seminars in Vascular Surgery

Volumn 22, Issue 3, 2009, Pages 145-151

  Tang, Daniel G ^a   Dake, Michael D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RESERPINE; TRIMETAPHAN;

AORTA DISSECTING ANEURYSM; AORTA GRAFT; ARTICLE; ASCENDING AORTA; CLINICAL TRIAL; DESCENDING AORTA; ENDOVASCULAR SURGERY; GRAFT PATENCY; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONG TERM CARE; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STENT; SURGICAL TECHNIQUE; THORACIC ENDOVASCULAR AORTIC REPAIR;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTOGRAPHY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 70249114805     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2009.07.005     Document Type: Article

References (45)

1. Mészáros I., Mórocz J., Szlávi J., et al. Epidemiology and clinicopathology of aortic dissection. Chest 117 (2000) 1271-1278
2. Acosta S., Blomstrand D., and Gottsäter A. Epidemiology and long-term prognostic factors in acute type B aortic dissection. Ann Vasc Surg 21 (2007) 415-422
3. Clouse W.D., Hallett J.W., Schaff H.V., et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc 79 (2004) 176-180
4. Wheat M.W., Palmer R.F., Bartley T.D., and Seelman R.C. Treatment of dissecting aneurysms of the aorta without surgery. J Thorac Cardiovasc Surg 50 (1965) 364-373
5. Daily P.O., Trueblood H.W., Stinson E.B., Wuerflein R.D., and Shumway N.E. Management of acute aortic dissections. Ann Thorac Surg 10 (1970) 237-247
6. Elefteriades J.A., Lovoulos C.J., Coady M.A., Tellides G., Kopf G.S., and Rizzo J.A. Management of descending aortic dissection. Ann Thorac Surg 67 (1999) 2002-2005
7. Hagan P.G., Nienaber C.A., Isselbacher E.M., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283 (2000) 897-903
8. Estrera A.L., Miller C.C., Safi H.J., et al. Outcomes of medical management of acute type B aortic dissection. Circulation 114 (2006) I384-I389
9. Svensson L.G., Kouchoukos N.T., Miller D.C., et al. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 85 suppl (2008) S1-S41
10. Winnerkvist A., Lockowandt U., Rasmussen E., and Rådegran K. A prospective study of medically treated acute type B aortic dissection. Eur J Vasc Endovasc Surg 32 (2006) 349-355
11. Glower D.D., Speier R.H., White W.D., Smith L.R., Rankin J.S., and Wolfe W.G. Management and long-term outcome of aortic dissection. Ann Surg 214 (1991) 31-41
12. Tsai T.T., Fattori R., Trimarchi S., et al., International Registry of Acute Aortic Dissection (IRAD). Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation 114 (2006) 2226-2231
13. Marui A., Mochizuki T., Mitsui N., Koyama T., Kimura F., and Horibe M. Toward the best treatment for uncomplicated patients with type B acute aortic dissection: a consideration for sound surgical indication. Circulation 100 (1999) 275-280
14. Gysi J., Schaffner T., Mohacsi P., Aeschbacher B., Althaus U., and Carrel T. Early and late outcome of operated and non-operated acute dissection of the descending aorta. Eur J Cardiothorac Surg 11 (1997) 1163-1170
15. Umaña J.P., Lai D.T., Mitchell R.S., et al. Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections?. J Thorac Cardiovasc Surg 124 (2002) 896-910
16. Hata M., Shiono M., Inoue T., et al. Optimal treatment of type B acute aortic dissection: long-term medical follow-up results. Ann Thorac Surg 75 (2003) 1781-1784
17. Juvonen T., Ergin M., Galla J.D., et al. Risk factors for rupture of chronic type B dissections. J Thorac Cardiovasc Surg 117 (1999) 776-786
18. Song J., Kim S., Kim J., et al. Long-term predictors of descending aorta aneurysmal change in patients with aortic dissection. J Am Coll Cardiol 50 (2007) 799-804
19. Genoni M., Paul M., Jenni R., Graves K., Seifert B., and Turina M. Chronic [beta]-blocker therapy improves outcome and reduces treatment costs in chronic type B aortic dissection. Eur J Cardiothorac Surg 19 (2001) 606-610
20. Kodama K., Nishigami K., Sakamoto T., et al. Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 118 (2008) S167-S170
21. Takeshita S., Sakamoto S., Kitada S., Akutsu K., and Hashimoto H. Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection. Circ J 72 (2008) 1758-1761
22. Claridge M.W., Hobbs S.D., Quick C.R., Day N.E., Bradbury A.W., and Wilmink A.B.M. ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 28 (2004) 67-70
23. Ahimastos A.A., Natoli A.K., Lawler A., Blombery P.A., and Kingwell B.A. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension 45 (2005) 1194-1199
24. da Cunha V., Tham D.M., Martin-McNulty B., et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 178 (2005) 9-17
25. Nagashima H., Uto K., Sakomura Y., et al. An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg 36 (2002) 818-823
26. Brooke B.S., Habashi J.P., Judge D.P., Patel N., Loeys B., and Dietz H.C. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358 (2008) 2787-2795
27. Trimarchi S., Nienaber C.A., Rampoldi V., et al., IRAD Investigators. Role and results of surgery in acute type B aortic dissection: Insights From the International Registry of Acute Aortic Dissection (IRAD). Circulation 114 (2006) I-357-I-364
28. Lansman S.L., Hagl C., Fink D., et al. Acute type B aortic dissection: surgical therapy. Ann Thorac Surg 74 (2002) S1833-S1835
29. Dake M.D., Kato N., Mitchell R.S., et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 340 (1999) 1546-1552
30. Nienaber C.A., Fattori R., Lund G., et al. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med 340 (1999) 1539-1545
31. Nienaber C.A., Kische S., Zeller T., et al. Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther 13 (2006) 738-746
32. Fattori R., Tsai T.T., Myrmel T., et al. Complicated acute type B dissection: is surgery still the best option?: A Report From the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv 1 (2008) 395-402
33. Parker J.D., and Golledge J. Outcome of endovascular treatment of acute type B aortic dissection. Ann Thorac Surg 86 (2008) 1707-1712
34. Nienaber C.A., Zannetti S., Barbieri B., Kische S., Schareck W., and Rehders T.C. INvestigation of STEnt grafts in patients with type B Aortic Dissection: design of the INSTEAD trial-a prospective, multicenter, European randomized trial. Am Heart J 149 (2005) 592-599
35. Nienaber C. Results from the INSTEAD trial. Sixth Annual International Symposium on Advances in Understanding Aortic Diseases (October 30, 2005) Berlin, Germany
36. Crawford E.S. The diagnosis and management of aortic dissection. JAMA 264 (1990) 2537-2541
37. Bortone A.S., Schena S., D'Agostino D., et al. Immediate versus delayed endovascular treatment of post-traumatic aortic pseudoaneurysms and type B dissections: retrospective analysis and premises to the upcoming European trial. Circulation 106 (2002) I-234-I-240
38. Akin I., Kische S., Ince H., and Nienaber C. Indication, timing and results of endovascular treatment of type B dissection. Eur J Vasc Endovasc Surg 37 (2009) 289-296
39. Coady M.A., Rizzo J.A., Hammond G.L., et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms?. J Thorac Cardiovasc Surg 113 (1997) 476-491
40. Davies R.R., Gallo A., Coady M.A., et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg 81 (2006) 169-177
41. Nathanson D.R., Rodriguez-Lopez J.A., Ramaiah V.G., et al. Endoluminal stent-graft stabilization for thoracic aortic dissection. J Endovasc Ther 12 (2005) 354-359
42. Erbel R., Oelert H., Meyer J., et al. Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation 87 (1993) 1604-1615
43. Bernard Y., Zimmermann H., Chocron S., et al. False lumen patency as a predictor of late outcome in aortic dissection. Am J Cardiol 87 (2001) 1378-1382
44. Tsai T.T., Evangelista A., Nienaber C.A., et al. International Registry of Acute Aortic Dissection. Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 357 (2007) 349-359
45. Song T.K., Donayre C.E., Walot I., et al. Endograft exclusion of acute and chronic descending thoracic aortic dissections. J Vasc Surg 43 (2006) 247-258